Atlantic Therapeutics

Our vision is to enable millions of people each year to restore their pelvic floor, and thereby restore their control, confidence and active lifestyle.

We manufacture innovative pelvic floor muscle strengthening and nerve stimulation products of medical device quality, supported by strong clinical evidence and subjected to controlled product trials. We are at the leading edge of technological developments in muscle rehabilitation and conditioning and are pioneering clinically proven pelvic floor health solutions. Thousands of clinicians and customers rely on Atlantic Therapeutics products such as INNOVO® (www.restorethefloor.com) every day, and our products improve many thousands of lives every year. We continue to carry out rigorous clinical trials to support the use of Innovotherapy to treat bladder weakness.

Since launching in March 2016, Innovotherapy has become the leading choice for a safe, effective, home-based treatment for the causes, not just the symptoms, of bladder weakness. Innovotherapy is already available in the UK, France, Germany, Ireland and the Middle East with further launches planned in the near future.

Atlantic Therapeutics’ offices are located in Galway, on the Atlantic coast of Ireland, London and Salem, close to Lake Constance in Germany.

Who is affected by bladder weakness?

What is Innovotherapy?

Innovotherapy is a non-invasive way to restore your pelvic floor, treating the primary cause of urinary leaks rather than just masking the symptoms. Using a hand held controller that is attached to a two part garment, Innovotherapy sends targeted impulses via a set of conductive pads (attached to your upper thigh and buttocks) to safely and effectively activate all the muscles of the pelvic floor or to calm your bladder. It is a proven technology which has been designed to optimally strengthen your pelvic floor with 180 perfect contractions per session, allowing the device to do your pelvic floor exercises for you. No it’s not cheating, it’s just very clever. Innovotherapy, already used by thousands of women and men, is safe and can be used in the privacy and comfort of your home for lasting results.

A non-invasive, clinically proven therapy

Distributors

Atlantic Therapeutics is proud to work with knowledgeable, driven partners to give us the best possible understanding of local market needs and to provide our customers with the highest possible level of service.

For information about how you can access Innovotherapy in your country, please contact us.

If you are interested in joining Atlantic Therapeutics’ distribution network as we introduce our clinically proven, safe and effective treatment globally, please contact us through info@atlantictherapeutics.com.

Ambassadors

We know that bladder weakness is a difficult subject to bring up, so at Atlantic Therapeutics we’re keen to support and reward ambassadors who are open to discussing and promoting a clinically proven solution that will help to improve their customers’ quality of life. Contact us today to find out how you can join Atlantic Therapeutics growing network of Innovotherapy Ambassadors.

Corporate Information

Atlantic Therapeutics develops professional and consumer medical devices, related software, apps and connected health technologies to treat all types of incontinence, sexual health dysfunctions, and other associated disorders by strengthening muscles and modulating nerves of the pelvic floor. All Atlantic Therapeutics Group Ltd. products are certified under the European Medical Devices Directive 93/42/EEC.

Atlantic Therapeutics Group Ltd, has recently successfully completed a €15 million growth capital financing, enabling the company to move forward with the next phase of growth and treat millions of people across the globe who suffer from bladder weakness, clinically known as stress urinary incontinence. 

The funds come from a combination of venture capital investment from Seroba Life Sciences and Earlybird Venture Capital, as well as Bio-medical Research Group Ltd (previous owner) which retains a minority shareholding. The capital enables Atlantic Therapeutics to accelerate growth from INNOVO® technology platform via market and geographic expansion and new product development. 

Board of Directors

Mr Steve Atkinson, Chief Executive Officer

Mr Padraic Clarke, Chief Financial Officer

Dr Daniel O'Mahoney, Partner with Seroba Life Science

Thom Rasche, Partner at Earlybird

Dr Bernard Collins, Chairman of Biomedical Research

Medical Advisory Board Members

Professor François Haab is a world leading urologist practicing in Urologie Paris Opéra and was previously Director of Urology at Hôpital Tenon (Assistance Publique)

Professor Ralf Tunn is Head of the Department of Urogynecology in Berlin and coordinator of the “Deutsches Beckenbodenzentrum” (German Pelvic Floor Centres)

Professor Linda Cardozo is an internationally recognised key opinion leader, Professor of Urogynaecology and Consultant Gynaecologist at King’s College Hospital, London

Prof Roger R Dmochowski is Professor at the Department of Urology and Director of the Section of Female Pelvic Medicine at Vanderbilt University in Nashville

Non-Medical Advisor: David Kaysen is ex-CEO of Uroplasty, Diametrics Medical and Compex Technologies and is on the board of Cefaly. Dave has extensive experience in the clinical application and commercialization of neuromodulation therapies.

Latest News

Atlantic Therapeutics receives €15 million in funding, led by Seroba Life Sciences and the Earlybird Health Technology Fund
Wednesday 1st March, 2017 06:45am

Contact Us